FDA NDC Directory · JSON-LD · Markdown

EMGALITY

NDC 0002-2377 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namegalcanezumab-gnlm
Labeler / ManufacturerEli Lilly and Company
Marketing categoryBiologic License Application · App BLA761063
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsGALCANEZUMAB (120 mg/mL)
Marketing started20180927
Package count1

External sources

Source: openFDA. Public-domain (CC0).